Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma.
Click here for original story, Histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma
Source: ScienceDaily